Skip to content

Stimulating self-management in irritable bowel syndrome through web-based interactive technology

Stimulating self-management in irritable bowel syndrome through web-based interactive technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27722
Enrollment
60
Registered
2007-05-21
Start date
2006-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome IBS Self-management Information and communication technology ICT Prikkelbare darmsyndroom PDS Informatie en communicatie technologie

Interventions

Standard care (control condition) + 4 daily electronic diaries during 5 weeks following ABA design (experimental condition): - 1 week baseline - a psychologist on 4 daily diaries - 1 week follow-up

Sponsors

NIVEL, Nederlands instituut voor onderzoek van de gezondheidszorg
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. IBS for at least three months; 2. Age between 18 and 65 years

Exclusion criteria

Exclusion criteria: 1. sufficient command of Dutch language 2. No visual handicap 3. Concomitant or previous psychotherapeutic treatment

Design outcomes

Primary

MeasureTime frame
IBS-severity, measured by 1. IBS Rome III criteria list 2. abdominal pain 3. secondary gastrointestinal complaints (diarrhea, constipation, flatulence, belching, abdominal rumbling and distension) All administered at baseline and at 12 weeks; all except (1) also at 5 weeks

Secondary

MeasureTime frame
1. Quality of life (IBS Quality of Life) 2. Daily functioning (SF-12) 3. Cognitions (Cognitive Scale – Functional Bowel Disorders) 4. Pijnattributies (Pain Cognition Scale) All administered at baseline (0 weeks), 5 weeks, and 12 weeks.

Contacts

Public ContactM. Morren

NIVEL, Nederlands instituut voor onderzoek van de gezondheidszorg Postbus 1568

m.morren@nivel.nl+31 30-2729700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)